Predictive factors for liver abscess liquefaction degree based on clinical, laboratory, and computed tomography data

doi:10.4240/wjgs.v17.i4.104615

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (409)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

HTML

119

Figures (1-3)

Tables (1-2)

Sum=220

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=132

Publishing Process of This Article

Item

Count

Browse

Download

Sum=47

Apr 27, 2025 (publication date) through Apr 9, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Surg. Apr 27, 2025; 17(4): 104615
Published online Apr 27, 2025. doi: 10.4240/wjgs.v17.i4.104615

Table 1 Clinical characteristics and laboratory indicators of patients, n (%)

Variables	PL (n = 28)	WL (n = 82)	Univariate analysis		Multivariate analysis
Variables	PL (n = 28)	WL (n = 82)	Z value	P value	P value	OR (95%CI)
Gender	19 (67.9)	51 (62.2)	-0.535	0.591
Age (years), median (25^th, 75^th percentiles)	69.00 (62.00, 77.00)	68.00 (56.00, 73.00)	-0.563	0.574
BMI, median (25^th, 75^th percentiles)	22.97 (20.82, 27.31)	22.69 (20.40, 26.15)	-0.161	0.872
Malignancy	4 (14.3)	18 (22.0)	0.872	0.381
Diabetes	20 (71.4)	38 (46.3)	-2.285	0.022^a	0.044^a	0.338 (0.118-0.971)
Hypertension	7 (25.0)	30 (27.6)	1.115	0.263
Cholecystitis	3 (10.7)	12 (14.6)	0.519	0.602¹
Fever	20 (71.4)	56 (68.3)
Pneumonia	11 (39.3)	10 (12.2)	-3.135	0.002^a	0.018^a	0.213 (0.059-0.764)
Consciousness disturbance	0 (0.0)	13 (15.9)	2.233	0.057¹
Respiratory dysfunction	1 (3.6)	14 (17.1)	1.789	0.139¹
Laboratory tests, median (25^th, 75^th percentiles)
WBC (× 10⁹/L)	10.27 (8.58, 13.49)	11.45 (9.04, 14.21)	-0.650	0.948
LYM (%)	10.90 (5.32, 16.18)	7.60 (4.62, 12.77)	-1.047	0.295
HCT (%)	32.85 (28.95, 37.25)	32.10 (28.78, 36.40)	-1.161	0.246
NP (%)	81.55 (75.35, 87.85)	84.30 (77.35, 88.90)	-1.060	0.289
PLT (× 10⁹/L)	240.50 (162.25, 357.50)	212.00 (130.75, 287.50)	-0.419	0.676
PT (seconds)	12.85 (12.10, 13.38)	13.35 (12.20, 14.03)	-1.644	0.100
INR	1.12 (1.08, 1.18)	1.17 (1.07, 1.27)	-0.738	0.461
TT (seconds)	15.75 (15.15, 17.28)	16.70 (15.60, 17.50)	-1.411	0.158
Cr (μmol/L)	60.95 (54.05, 76.45)	62.50 (52.78, 85.25)	-1.215	0.224
Urea (mmol/L)	5.18 (4.13, 5.91)	5.11 (3.72, 8.65)	-1.562	0.118
TBIL (μmol/L)	17.25 (11.98, 25.98)	18.05 (13.30, 28.03)	-0.532	0.595
ALT (U/L)	33.35 (21.45, 71.25)	49.90 (32.90, 95.50)	-2.350	0.019	0.041^a	1.013 (1.001-1.025)
GGT (U/L)	119.00 (90.00, 204.75)	124.50 (62.75, 238.25)	-1.517	0.129
FIB (g/L)	6.70 (5.58, 7.74)	6.40 (4.47, 7.49)	-1.379	0.168
TP (g/L)	59.80 (54.55, 67.35)	60.60 (54.50, 65.10)	-0.546	0.585
GLOB (g/L)	30.70 (27.53, 37.53)	31.55 (27.63, 36.60)	-0.384	0.701
ALB (g/L)	28.35 (24.83, 31.50)	27.45 (24.78, 32.33)	-0.254	0.800
A/G ratio	0.93 (0.78, 1.05)	0.90 (0.73, 1.05)	-0.620	0.951

^aP < 0.05.

¹P calculated χ² exact test.

PL: Poor liquefaction; WL: Well liquefaction; OR: Odds ratio; CI: Confidence interval; BMI: Body mass index; WBC: White blood cell; LYM: Lymphocyte percentage; HCT: Hematocrit; NP: Neutrophil percentage; PLT: Platelet count; PT: Prothrombin time; INR: International normalized ratio; TT: Thrombin time; Cr: Creatinine; TBIL: Total bilirubin; ALT: Alanine aminotransferase; GGT: Gamma-glutamyl transferase; FIB: Fibrinogen; TP: Total protein; GLOB: Globulin; ALB: Albumin; A/G ratio: Albumin/globulin ratio.

Table 2 Comparison of patient computed tomography characteristics, n (%)

CT features	PL (n = 28)	WL (n = 82)	Univariate analysis		Multivariate analysis
CT features	PL (n = 28)	WL (n = 82)	Z value	P value	P value	OR (95%CI)
Lesion volume (cm³), median (25^th, 75^th percentiles)	110.45 (89.16, 207.13)	88.48 (37.68, 164.03)	-2.107	0.035^a	0.919	1.00 (1.00-1.00)
Mean CT value (HU), median (25^th, 75^th percentiles)	25.10 (19.93, 29.47)	23.04 (17.50, 27.19)	-1.496	0.135
Median CT value (HU), median (25^th, 75^th percentiles)	26.00 (21.00, 29.75)	23.00 (19.00, 27.00)	-1.506	0.132
10% CT value (HU), median (25^th, 75^th percentiles)	6.50 (-2.75, 10.75)	3.50 (-3.50, 10.00)	-0.666	0.505
90% CT value (HU), median (25^th, 75^th percentiles)	44.00 (39.50, 49.75)	43.00 (38.00, 49.25)	-0.721	0.471
CT value range (HU), median (25^th, 75^th percentiles)	38.50 (28.00, 51.00)	37.50 (29.75, 51.00)	-0.779	0.436
Maximum cross-sectional diameter (cm), median (25^th, 75^th percentiles)	7.50 (6.57, 8.79)	7.23 (5.42, 9.31)	-1.118	0.263
Maximum 3D diameter (cm), median (25^th, 75^th percentiles)	8.32 (7.46, 10.43)	8.23 (6.33, 10.41)	-0.837	0.403
Abscess location (left lobe)	3 (10.7)	50 (61.0)	-2.764	0.005^a	0.041^a	4.305 (1.065-17.404)
Presence of gas	4 (14.3)	17 (20.3)	0.746	0.454
Cystic appearance	3 (10.7)	28 (34.1)	2.369	0.017^a	0.028^a	5.037 (1.187-21.378)

^aP < 0.05.

PL: Poor liquefaction; WL: Well liquefaction; OR: Odds ratio; CI: Confidence interval; CT: Computed tomography; HU: Hounsfield unit; 3D: Three dimensional.

Citation: Long HY, Yan X, Meng JX, Xie F. Predictive factors for liver abscess liquefaction degree based on clinical, laboratory, and computed tomography data. World J Gastrointest Surg 2025; 17(4): 104615
URL: https://www.wjgnet.com/1948-9366/full/v17/i4/104615.htm
DOI: https://dx.doi.org/10.4240/wjgs.v17.i4.104615